Screener
Vera Therapeutics VERA Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Vera Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:33 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212143
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Marketable securities | 482,409 | 359,864 |
| Prepaid expenses and other assets, current | 19,042 | 14,294 |
| Total current assets | 615,802 | 728,883 |
| Other assets, noncurrent | 5,937 | 5,850 |
| Total assets | $621,739 | $734,733 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $13,909 | $21,898 |
Item 1. Financial Statements
FAQ
- What is Vera Therapeutics's deferred tax assets and other non-current assets?
- Vera Therapeutics (VERA) reported deferred tax assets and other non-current assets of $5.94M in Q1 2026.
Ask your AI about Vera Therapeutics's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude